Keudell/Morrison Wealth Management’s Biogen BIIB Stock Holding History

Keudell/Morrison Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-753	Closed	-$213K	–	189
2021 Q3	$213K	Hold	753	–	–	0.09%	166
2021 Q2	$261K	Buy	+753	New	+$228K	0.14%	145
2021 Q1	–	Sell	-953	Closed	-$233K	–	170
2020 Q4	$233K	Hold	953	–	–	0.15%	144
2020 Q3	$270K	Sell	953 -21	-2%	-$5.86K	0.17%	121
2020 Q2	$261K	Sell	974 -83	-8%	-$24.9K	0.22%	120
2020 Q1	$334K	Sell	1,057 -230	-18%	-$69.8K	0.33%	96
2019 Q4	$382K	Sell	1,287 -54	-4%	-$15K	0.26%	98
2019 Q3	$312K	Buy	1,341 +25	+2%	+$5.82K	0.26%	108
2019 Q2	$313K	Sell	1,316 -588	-31%	-$136K	0.27%	104
2019 Q1	$450K	Buy	+1,904	New	+$600K	0.4%	83

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Keudell/Morrison Wealth Management's BIIB Position: Q4 2021 in Review

Keudell/Morrison Wealth Management sold out of Biogen (BIIB) in Q4 2021, closing a stake of 753 shares — an estimated $213K sold.

Keudell/Morrison Wealth Management first reported a position in BIIB in Q1 2019 and held it in 10 quarters. The position peaked at $450K in Q1 2019. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

Keudell/Morrison Wealth Management reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
Keudell/Morrison Wealth Management sold 753 Biogen shares in Q4 2021, an estimated $213K.
Keudell/Morrison Wealth Management first reported a position in Biogen in Q1 2019 and held it in 10 quarters.
Keudell/Morrison Wealth Management's Biogen position peaked at $450K in Q1 2019.
1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Keudell/Morrison Wealth Management's 13F filing for Q4 2021, filed 8 Feb 2022.